CIENCE CIENCEa graph8 company
+ New search
Your company
24 companies like Finch Therapeutics
Finch Therapeutics logo

Finch Therapeutics

finchtherapeutics.com
Finch Therapeutics is a microbiome therapeutics company with a portfolio of investigational microbiome assets, including CP101 — a late-stage, orally administered microbiome candidate with positive Phase 2 clinical data in recurrent C. difficile infection — and pre-clinical assets targeting ulcerative colitis, Crohn's disease, and autism spectrum disorder.
HFMP
201711-50 emp
Somerville, Massachusetts
Biotechnology Research
NAICS 541714
1717•••••23
TECH STACK
BootstrapCloudflareCloudflare Browser InsightsGoogle AnalyticsGoogle Tag ManagerHTTP/3MDBootstrapMySQLPHPPopperSVG SupportWP Engine
Finch Therapeutics campaignconsultative3000 target
Companies like Finch Therapeutics — Biotechnology Research, 11-50
“Lead with strategic value of differentiated microbiome IP and clinical-stage assets for GI and adjacent indications through licensing, partnership, or portfolio expansion.”
Launch outbound on autopilot

Personalised emails written for every contact · 97% deliverability · live in 60 seconds

Companies 17
Decision-makers 30
Emails 20
Signals 0

Companies like Finch Therapeutics — competitors and alternatives

CompanyWhat they doLocationSizeHiring
Finch Therapeuticsfinchtherapeutics.com
HFWKPP
Finch Therapeutics is a microbiome therapeutics company with a portfolio of investigational microbiome assets, including CP101 — aSomerville, Massachusetts11-50
Seres Therapeuticsserestherapeutics.com
DMPMRS
Seres Therapeutics is a commercial-stage biotechnology company developing novel microbiome therapeutics for serious diseases, withCambridge, Massachusetts51-200
Rebiotix Increbiotix.com
KBBSDM
Rebiotix Inc is a clinical-stage biotechnology company that develops microbiome-based therapies to treat challenging gastrointestiRoseville, Minnesota51-200
3Ahealth3ahealth.com
DKCI
VEDANTA PRESSvedanta.com
Vedanta Press and Catalog is a non-profit publishing imprint of the Vedanta Society of Southern California that publishes and sellLos Angeles, California11-50
EWNI
Kaleido is a biotechnology research company founded in 2015 and based in Lexington, Massachusetts, that pursues life-changing therLexington, Massachusetts1-10
Enteromeenterome.com
JFACJG
Enterome is a clinical-stage biopharmaceutical company developing OncoMimics™ peptide immunomodulatory drugs for cancer, using a gParis, France51-200
L(MBAC
BiomX is a defense and security company building a portfolio of detection, aerial, and intelligence systems through subsidiaries,
Symbiotixhealthsymbiotixhealth.com
Secondgenbiosecondgenbio.com
Symbiotixsymbiotix.com
LWGDJB
Symbiotix is a scientific medical communications agency, the US-based flagship of the Havas Health & You network, that translates Lexington, Kentucky51-200
Microbioticamicrobiotica.com
RTAWRK
Microbiotica is a clinical-stage biopharmaceutical company translating clinic-led microbiome science into defined live biotherapeuCambridge, Cambridgeshire51-200
Genome Internationalgenome.com
MGJSSM
Genome International is a Bio-IT company that provides clinical genomics software and services, including Genome Explorer, a wholeMadison, Wisconsin51-200
4Dhealth4dhealth.com
N4BF
4D Health is a clinical simulation center in Igualada, Barcelona, operating a 2,500m² facility with a 4D clinical simulation cente
Probiogenprobiogen.com
Axial Biotherapeuticsaxialbiotherapeutics.com
Axial Therapeutics is a clinical-stage biopharmaceutical company developing gut-restricted, small molecule therapeutics for centraWoburn, Massachusetts51-200
Run live for more

Agent activity

Done
$fetch_profilefinchtherapeutics.com
Found: Finch Therapeutics
$analyze_identityfinchtherapeutics.com
Finch Therapeutics is a microbiome therapeutics company with a portfolio of investigational microbiome assets, including CP101 — a late-stage, orally administered microbiome candid
$search_companiescompanies like Finch Therapeutics
24 companies
$search_peopledecision-makers

Frequently asked questions about Finch Therapeutics

What does Finch Therapeutics do?

Finch Therapeutics is a microbiome therapeutics company with a portfolio of investigational microbiome assets, including CP101 — a late-stage, orally administered microbiome candidate with positive Phase 2 clinical data in recurrent C. difficile infection — and pre-clinical assets targeting ulcerative colitis, Crohn's disease, and autism spectrum disorder.

Who are Finch Therapeutics's competitors?

Companies like Finch Therapeutics include Seres Therapeutics, Rebiotix Inc, 3Ahealth, VEDANTA PRESS, Kaleido. See the full list of 24 competitors and alternatives above.

How many employees does Finch Therapeutics have?

Finch Therapeutics has approximately 11-50 employees and is in the Biotechnology Research industry.

Where is Finch Therapeutics headquartered?

Finch Therapeutics is headquartered in Somerville, Massachusetts.

What industry is Finch Therapeutics in?

Finch Therapeutics operates in the Biotechnology Research industry.

Who are the decision-makers at Finch Therapeutics?

Key decision-makers and buying contacts at Finch Therapeutics are listed above, including leaders across executive, finance, sales and operations.